Abstract
Metastatic cancer is a complex disease associated with poor prognosis and accounts for the majority of cancer related deaths. To date, many of the molecular mechanisms driving metastatic disease remain elusive and require further investigation for the development of effective treatment strategies. Recent studies have shown that extracellular vesicles (EVs) can be exploited by tumors to assist in cancer cell growth, proliferation, migration, invasion and metastasis. Cancer cells have proven efficient in educating fibroblasts, within their microenvironment, to secrete EVs as communicative vessels for mediating phenotypic changes in recipient cells. Using this vesicular delivery system, cancer cells can establish a new metastatic niche within distant sites, away from the primary tumor, thus favoring cancer progression. These findings demonstrate the availability of a new route for therapeutic intervention in the inhibition of cancer dissemination. Although, several approaches to target cancer cell secretion of EVs are detailed in the literature, there is still no defined way to currently apply them in clinical settings. Hence, further studies are required to unravel the molecular mechanisms of metastasis - governed by the establishment and release of cancer associated EVs.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aigner K, Dampier B, Descovich L, Mikula M, Sultan A, Schreiber M, Mikulits W, Brabletz T, Strand D, Obrist P, Sommergruber W, Schweifer N, Wernitznig A, Beug H, Foisner R, Eger A (2007) The transcription factor ZEB1 (δEF1) promotes tumour cell dedifferentiation by repressing master regulators of epithelial polarity. Oncogene 26(49):6979–6988. https://doi.org/10.1038/sj.onc.1210508
Allard B, Longhi MS, Robson SC, Stagg J (2017) The ectonucleotidases CD39 and CD73: novel checkpoint inhibitor targets. Immunol Rev 276(1):121–144. https://doi.org/10.1111/imr.12528
Anand S, Samuel M, Kumar S, Mathivanan S (2019) Ticket to a bubble ride: cargo sorting into exosomes and extracellular vesicles. Biochim Biophys Acta Proteins Proteom. https://doi.org/10.1016/j.bbapap.2019.02.005
Becker A, Thakur BK, Weiss JM, Kim HS, Peinado H, Lyden D (2016) Extracellular vesicles in cancer: cell-to-cell mediators of metastasis. Cancer Cell 30(6):836–848. https://doi.org/10.1016/j.ccell.2016.10.009
Beghein E, Devriese D, Van Hoey E, Gettemans J (2018) Cortactin and fascin-1 regulate extracellular vesicle release by controlling endosomal trafficking or invadopodia formation and function. Sci Rep 8(1):15606. https://doi.org/10.1038/s41598-018-33868-z
Biswas S, Mandal G, Roy Chowdhury S, Purohit S, Payne KK, Anadon C, Gupta A, Swanson P, Yu X, Conejo-Garcia JR, Bhattacharyya A (2019) Exosomes produced by Mesenchymal stem cells drive differentiation of myeloid cells into immunosuppressive M2-polarized macrophages in breast cancer. J Immunol 203(12):3447–3460. https://doi.org/10.4049/jimmunol.1900692
Bobrie A, Krumeich S, Reyal F, Recchi C, Moita LF, Seabra MC, Ostrowski M, Théry C (2012) Rab27a supports exosome-dependent and -independent mechanisms that modify the tumor microenvironment and can promote tumor progression. Cancer Res 72(19):4920–4930. https://doi.org/10.1158/0008-5472.Can-12-0925
Boukouris S, Mathivanan S (2015) Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteomics Clin Appl 9(3–4):358–367. https://doi.org/10.1002/prca.201400114
Catalano M, O’Driscoll L (2020) Inhibiting extracellular vesicles formation and release: a review of EV inhibitors. Journal of Extracellular Vesicles 9(1):1703244. https://doi.org/10.1080/20013078.2019.1703244
Chen G, Huang AC, Zhang W, Zhang G, Wu M, Xu W, Yu Z, Yang J, Wang B, Sun H, Xia H, Man Q, Zhong W, Antelo LF, Wu B, Xiong X, Liu X, Guan L, Li T, Liu S, Yang R, Lu Y, Dong L, McGettigan S, Somasundaram R, Radhakrishnan R, Mills G, Lu Y, Kim J, Chen YH, Dong H, Zhao Y, Karakousis GC, Mitchell TC, Schuchter LM, Herlyn M, Wherry EJ, Xu X, Guo W (2018) Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560(7718):382–386. https://doi.org/10.1038/s41586-018-0392-8
Cheng Q, Li X, Wang Y, Dong M, Zhan F-h, Liu J (2018) The ceramide pathway is involved in the survival, apoptosis and exosome functions of human multiple myeloma cells in vitro. Acta Pharmacol Sin 39(4):561–568. https://doi.org/10.1038/aps.2017.118
Chitti SV, Fonseka P, Mathivanan S (2018) Emerging role of extracellular vesicles in mediating cancer cachexia. Biochem Soc Trans 46(5):1129–1136. https://doi.org/10.1042/BST20180213
Cho JA, Park H, Lim EH, Lee KW (2012) Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells. Int J Oncol 40(1):130–138. https://doi.org/10.3892/ijo.2011.1193
Ciardiello C, Cavallini L, Spinelli C, Yang J, Reis-Sobreiro M, de Candia P, Minciacchi VR, Di Vizio D (2016) Focus on extracellular vesicles: new Frontiers of cell-to-cell communication in cancer. Int J Mol Sci 17(2):175–175. https://doi.org/10.3390/ijms17020175
Conigliaro A, Cicchini C (2018) Exosome-mediated signaling in epithelial to Mesenchymal transition and tumor progression. J Clin Med 8(1):26. https://doi.org/10.3390/jcm8010026
Datta A, Kim H, McGee L, Johnson AE, Talwar S, Marugan J, Southall N, Hu X, Lal M, Mondal D, Ferrer M, Abdel-Mageed AB (2018) High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: a drug repurposing strategy for advanced cancer. Sci Rep 8(1):8161. https://doi.org/10.1038/s41598-018-26411-7
Donnarumma E, Fiore D, Nappa M, Roscigno G, Adamo A, Iaboni M, Russo V, Affinito A, Puoti I, Quintavalle C, Rienzo A, Piscuoglio S, Thomas R, Condorelli G (2017) Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer. Oncotarget 8(12):19592–19608. https://doi.org/10.18632/oncotarget.14752
Ekström EJ, Bergenfelz C, von Bülow V, Serifler F, Carlemalm E, Jönsson G, Andersson T, Leandersson K (2014) WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells. Mol Cancer 13:88. https://doi.org/10.1186/1476-4598-13-88
Espinoza JL, Takami A, Yoshioka K, Nakata K, Sato T, Kasahara Y, Nakao S (2012) Human microRNA-1245 down-regulates the NKG2D receptor in natural killer cells and impairs NKG2D-mediated functions. Haematologica 97(9):1295–1303. https://doi.org/10.3324/haematol.2011.058529
Faict S, Muller J, De Veirman K, De Bruyne E, Maes K, Vrancken L, Heusschen R, De Raeve H, Schots R, Vanderkerken K, Caers J, Menu E (2018) Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts. Blood Cancer J 8(11):105. https://doi.org/10.1038/s41408-018-0139-7
Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y (2020) Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther 5(1):28. https://doi.org/10.1038/s41392-020-0134-x
Fidler IJ (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3(6):453–458. https://doi.org/10.1038/nrc1098
Fonseka P, Liem M, Ozcitti C, Adda CG, Ang CS, Mathivanan S (2019) Exosomes from N-Myc amplified neuroblastoma cells induce migration and confer chemoresistance to non-N-Myc amplified cells: implications of intra-tumor heterogeneity. J Extracell Vesicles 8(1):1597614
Gangoda L, Boukouris S, Liem M, Kalra H, Mathivanan S (2015) Extracellular vesicles including exosomes are mediators of signal transduction: are they protective or pathogenic? Proteomics 15(2–3):260–271. https://doi.org/10.1002/pmic.201400234
Gangoda L, Liem M, Ang C-S, Keerthikumar S, Adda CG, Parker BS, Mathivanan S (2017) Proteomic profiling of Exosomes secreted by breast cancer cells with varying metastatic potential. Proteomics 17(23–24):1600370. https://doi.org/10.1002/pmic.201600370
Gowda R, Robertson BM, Iyer S, Barry J, Dinavahi SS, Robertson GP (2020) The role of exosomes in metastasis and progression of melanoma. Cancer Treat Rev 85:101975. https://doi.org/10.1016/j.ctrv.2020.101975
Guo Y, Ji X, Liu J, Fan D, Zhou Q, Chen C, Wang W, Wang G, Wang H, Yuan W, Ji Z, Sun Z (2019) Effects of exosomes on pre-metastatic niche formation in tumors. Mol Cancer 18(1):39. https://doi.org/10.1186/s12943-019-0995-1
Hao S, Ye Z, Li F, Meng Q, Qureshi M, Yang J, Xiang J (2006) Epigenetic transfer of metastatic activity by uptake of highly metastatic B16 melanoma cell-released exosomes. Exp Oncol 28(2):126–131
Harris DA, Patel SH, Gucek M, Hendrix A, Westbroek W, Taraska JW (2015) Exosomes released from breast cancer carcinomas stimulate cell movement. PLoS One 10(3):e0117495. https://doi.org/10.1371/journal.pone.0117495
Hollier BG, Tinnirello AA, Werden SJ, Evans KW, Taube JH, Sarkar TR, Sphyris N, Shariati M, Kumar SV, Battula VL, Herschkowitz JI, Guerra R, Chang JT, Miura N, Rosen JM, Mani SA (2013) FOXC2 expression links epithelial–Mesenchymal transition and stem cell properties in breast cancer. Cancer Res 73(6):1981–1992. https://doi.org/10.1158/0008-5472.Can-12-2962
Hoshino A, Costa-Silva B, Shen TL, Rodrigues G, Hashimoto A, Tesic Mark M, Molina H, Kohsaka S, Di Giannatale A, Ceder S, Singh S, Williams C, Soplop N, Uryu K, Pharmer L, King T, Bojmar L, Davies AE, Ararso Y, Zhang T, Zhang H, Hernandez J, Weiss JM, Dumont-Cole VD, Kramer K, Wexler LH, Narendran A, Schwartz GK, Healey JH, Sandstrom P, Labori KJ, Kure EH, Grandgenett PM, Hollingsworth MA, de Sousa M, Kaur S, Jain M, Mallya K, Batra SK, Jarnagin WR, Brady MS, Fodstad O, Muller V, Pantel K, Minn AJ, Bissell MJ, Garcia BA, Kang Y, Rajasekhar VK, Ghajar CM, Matei I, Peinado H, Bromberg J, Lyden D (2015) Tumour exosome integrins determine organotropic metastasis. Nature 527(7578):329–335. https://doi.org/10.1038/nature15756
Hsu YL, Hung JY, Chang WA, Lin YS, Pan YC, Tsai PH, Wu CY, Kuo PL (2017) Hypoxic lung cancer-secreted exosomal miR-23a increased angiogenesis and vascular permeability by targeting prolyl hydroxylase and tight junction protein ZO-1. Oncogene 36(34):4929–4942. https://doi.org/10.1038/onc.2017.105
Ichinose M, Masuoka J, Shiraishi T, Mineta T, Tabuchi K (2001) Fas ligand expression and depletion of T-cell infiltration in astrocytic tumors. Brain Tumor Pathol 18(1):37–42. https://doi.org/10.1007/bf02478923
Iguchi Y, Eid L, Parent M, Soucy G, Bareil C, Riku Y, Kawai K, Takagi S, Yoshida M, Katsuno M, Sobue G, Julien J-P (2016) Exosome secretion is a key pathway for clearance of pathological TDP-43. Brain 139(12):3187–3201. https://doi.org/10.1093/brain/aww237
Im EJ, Lee CH, Moon PG, Rangaswamy GG, Lee B, Lee JM, Lee JC, Jee JG, Bae JS, Kwon TK, Kang KW, Jeong MS, Lee JE, Jung HS, Ro HJ, Jun S, Kang W, Seo SY, Cho YE, Song BJ, Baek MC (2019) Sulfisoxazole inhibits the secretion of small extracellular vesicles by targeting the endothelin receptor a. Nat Commun 10(1):1387. https://doi.org/10.1038/s41467-019-09387-4
Johnstone RM, Adam M, Pan BT (1984) The fate of the transferrin receptor during maturation of sheep reticulocytes in vitro. Can J Biochem Cell Biol 62(11):1246–1254. https://doi.org/10.1139/o84-159
Jung KO, Youn H, Lee C-H, Kang KW, Chung J-K (2017) Visualization of exosome-mediated miR-210 transfer from hypoxic tumor cells. Oncotarget 8(6):9899–9910. https://doi.org/10.18632/oncotarget.14247
Kalluri R, LeBleu VS (2020) The biology function and biomedical applications of exosomes. Science 367(6478):eaau6977. https://doi.org/10.1126/science.aau6977
Kalra H, Drummen GPC, Mathivanan S (2016) Focus on extracellular vesicles: introducing the next small big thing. Int J Mol Sci 17(2):170–170. https://doi.org/10.3390/ijms17020170
Kalra H, Gangoda L, Fonseka P, Chitti SV, Liem M, Keerthikumar S, Samuel M, Boukouris S, Al Saffar H, Collins C, Adda CG, Ang CS, Mathivanan S (2019) Extracellular vesicles containing oncogenic mutant beta-catenin activate Wnt signalling pathway in the recipient cells. J Extracell Vesicles 8(1):1690217. https://doi.org/10.1080/20013078.2019.1690217
Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C, MacDonald DD, Jin DK, Shido K, Kerns SA, Zhu Z, Hicklin D, Wu Y, Port JL, Altorki N, Port ER, Ruggero D, Shmelkov SV, Jensen KK, Rafii S, Lyden D (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438(7069):820–827. https://doi.org/10.1038/nature04186
Kim E-S, Kim M-S, Moon A (2005) Transforming growth factor (TGF)-β in conjunction with H-ras activation promotes malignant progression of MCF10A breast epithelial cells. Cytokine 29(2):84–91
Kim H, Lee S, Shin E, Seong KM, Jin YW, Youn H, Youn B (2020) The emerging roles of Exosomes as EMT regulators in cancer. Cell 9(4):861
Krock BL, Skuli N, Simon MC (2011) Hypoxia-induced angiogenesis: good and evil. Genes Cancer 2(12):1117–1133. https://doi.org/10.1177/1947601911423654
Lazarova M, Steinle A (2019) Impairment of NKG2D-mediated tumor immunity by TGF-β. Front Immunol 10:2689–2689. https://doi.org/10.3389/fimmu.2019.02689
Leong Hon S, Robertson Amy E, Stoletov K, Leith Sean J, Chin Curtis A, Chien Andrew E, Hague MN, Ablack A, Carmine-Simmen K, McPherson Victor A, Postenka Carl O, Turley Eva A, Courtneidge Sara A, Chambers Ann F, Lewis John D (2014) Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasis. Cell Rep 8(5):1558–1570. https://doi.org/10.1016/j.celrep.2014.07.050
Li Q, Li B, Li Q, Wei S, He Z, Huang X, Wang L, Xia Y, Xu Z, Li Z, Wang W, Yang L, Zhang D, Xu Z (2018) Exosomal miR-21-5p derived from gastric cancer promotes peritoneal metastasis via mesothelial-to-mesenchymal transition. Cell Death Dis 9(9):854. https://doi.org/10.1038/s41419-018-0928-8
Li Y, Wang W, Wang W, Yang R, Wang T, Su T, Weng D, Tao T, Li W, Ma D, Wang S (2012) Correlation of TWIST2 up-regulation and epithelial-mesenchymal transition during tumorigenesis and progression of cervical carcinoma. Gynecol Oncol 124(1):112–118. https://doi.org/10.1016/j.ygyno.2011.09.003
Libring S, Shinde A, Chanda MK, Nuru M, George H, Saleh AM, Abdullah A, Kinzer-Ursem TL, Calve S, Wendt MK, Solorio L (2020) The dynamic relationship of breast cancer cells and fibroblasts in Fibronectin accumulation at primary and metastatic tumor sites. Cancers (Basel) 12(5). https://doi.org/10.3390/cancers12051270
Liem M, Ang CS, Mathivanan S (2017) Insulin mediated activation of PI3K/Akt signalling pathway modifies the proteomic cargo of extracellular vesicles. Proteomics. https://doi.org/10.1002/pmic.201600371
Lin XJ, Fang JH, Yang XJ, Zhang C, Yuan Y, Zheng L, Zhuang SM (2018) Hepatocellular carcinoma cell-secreted Exosomal MicroRNA-210 promotes angiogenesis in vitro and in vivo. Mol Ther Nucleic Acids 11:243–252. https://doi.org/10.1016/j.omtn.2018.02.014
Lo Cicero A, Stahl PD, Raposo G (2015) Extracellular vesicles shuffling intercellular messages: for good or for bad. Curr Opin Cell Biol 35:69–77. https://doi.org/10.1016/j.ceb.2015.04.013
Madeo M, Colbert PL, Vermeer DW, Lucido CT, Cain JT, Vichaya EG, Grossberg AJ, Muirhead D, Rickel AP, Hong Z, Zhao J, Weimer JM, Spanos WC, Lee JH, Dantzer R, Vermeer PD (2018) Cancer exosomes induce tumor innervation. Nat Commun 9(1):4284. https://doi.org/10.1038/s41467-018-06640-0
Mannavola F, Salerno T, Passarelli A, Tucci M, Internò V, Silvestris F (2019) Revisiting the role of Exosomes in colorectal cancer: where are we now? Front Oncol 9(521). https://doi.org/10.3389/fonc.2019.00521
Martınez-Lorenzo MJ, Anel A, Alava MA, Piñeiro A, Naval J, Lasierra P, Larrad L (2004) The human melanoma cell line MelJuSo secretes bioactive FasL and APO2L/TRAIL on the surface of microvesicles. Possible contribution to tumor counterattack. Exp Cell Res 295(2):315–329
Mathivanan S (2017) Extracellular matrix and the extracellular environment. Proteomics 17:23–24. https://doi.org/10.1002/pmic.2017700185
Mathivanan S, Ji H, Tauro BJ, Chen YS, Simpson RJ (2012) Identifying mutated proteins secreted by colon cancer cell lines using mass spectrometry. J Proteome
Mathivanan S, Lim JW, Tauro BJ, Ji H, Moritz RL, Simpson RJ (2010) Proteomics analysis of A33 immunoaffinity-purified exosomes released from the human colon tumor cell line LIM1215 reveals a tissue-specific protein signature. Mol Cell Proteomics 9(2):197–208
McAndrews KM, Kalluri R (2019) Mechanisms associated with biogenesis of exosomes in cancer. Mol Cancer 18(1):52. https://doi.org/10.1186/s12943-019-0963-9
McCready J, Sims JD, Chan D, Jay DG (2010) Secretion of extracellular hsp90α via exosomes increases cancer cell motility: a role for plasminogen activation. BMC Cancer 10(1):294. https://doi.org/10.1186/1471-2407-10-294
Meleth S, Whitehead N, Evans TS, Lux L (2013) AHRQ technology assessments. In: Technology assessment on genetic testing or molecular pathology testing of cancers with unknown primary site to determine origin. Agency for healthcare research and quality (US), Rockville (MD)
Mittelbrunn M, Sánchez-Madrid F (2012) Intercellular communication: diverse structures for exchange of genetic information. Nat Rev Mol Cell Biol 13(5):328–335. https://doi.org/10.1038/nrm3335
Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP, Goud B, Benaroch P, Hacohen N, Fukuda M, Desnos C, Seabra MC, Darchen F, Amigorena S, Moita LF, Thery C (2010) Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol 12(1):19–30; sup pp 11-13. https://doi.org/10.1038/ncb2000
Paget S (1989) The distribution of secondary growths in cancer of the breast. 1889. Cancer Metastasis Rev 8(2):98–101
Panigrahi GK, Praharaj PP, Peak TC, Long J, Singh R, Rhim JS, Abd Elmageed ZY, Deep G (2018) Hypoxia-induced exosome secretion promotes survival of African-American and Caucasian prostate cancer cells. Sci Rep 8(1):3853. https://doi.org/10.1038/s41598-018-22068-4
Pathan M, Fonseka P, Chitti SV, Kang T, Sanwlani R, Van Deun J, Hendrix A, Mathivanan S (2019) Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles. Nucleic Acids Res 47(D1):D516–D519. https://doi.org/10.1093/nar/gky1029
Peinado H, Alečković M, Lavotshkin S, Matei I, Costa-Silva B, Moreno-Bueno G, Hergueta-Redondo M, Williams C, García-Santos G, Ghajar C, Nitadori-Hoshino A, Hoffman C, Badal K, Garcia BA, Callahan MK, Yuan J, Martins VR, Skog J, Kaplan RN, Brady MS, Wolchok JD, Chapman PB, Kang Y, Bromberg J, Lyden D (2012) Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 18(6):883–891. https://doi.org/10.1038/nm.2753
Plebanek MP, Angeloni NL, Vinokour E, Li J, Henkin A, Martinez-Marin D, Filleur S, Bhowmick R, Henkin J, Miller SD, Ifergan I, Lee Y, Osman I, Thaxton CS, Volpert OV (2017) Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche. Nat Commun 8(1):1319. https://doi.org/10.1038/s41467-017-01433-3
Rodrigues G, Hoshino A, Kenific CM, Matei IR, Steiner L, Freitas D, Kim HS, Oxley PR, Scandariato I, Casanova-Salas I, Dai J, Badwe CR, Gril B, Tešić Mark M, Dill BD, Molina H, Zhang H, Benito-Martin A, Bojmar L, Ararso Y, Offer K, LaPlant Q, Buehring W, Wang H, Jiang X, Lu TM, Liu Y, Sabari JK, Shin SJ, Narula N, Ginter PS, Rajasekhar VK, Healey JH, Meylan E, Costa-Silva B, Wang SE, Rafii S, Altorki NK, Rudin CM, Jones DR, Steeg PS, Peinado H, Ghajar CM, Bromberg J, de Sousa M, Pisapia D, Lyden D (2019) Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis. Nat Cell Biol 21(11):1403–1412. https://doi.org/10.1038/s41556-019-0404-4
Rontogianni S, Synadaki E, Li B, Liefaard MC, Lips EH, Wesseling J, Wu W, Altelaar M (2019) Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping. Communications Biology 2(1):325. https://doi.org/10.1038/s42003-019-0570-8
Sanwlani R, Fonseka P, Chitti SV, Mathivanan S (2020) Milk-derived extracellular vesicles in inter-organism, cross-species communication and drug delivery. Proteomes 8(2). https://doi.org/10.3390/proteomes8020011
Seyfried TN, Huysentruyt LC (2013) On the origin of cancer metastasis. Crit Rev Oncog 18(1–2):43–73. https://doi.org/10.1615/critrevoncog.v18.i1-2.40
Sinha S, Hoshino D, Hong NH, Kirkbride KC, Grega-Larson NE, Seiki M, Tyska MJ, Weaver AM (2016) Cortactin promotes exosome secretion by controlling branched actin dynamics. J Cell Biol 214(2):197–213. https://doi.org/10.1083/jcb.201601025
Suchorska WM, Lach MS (2016) The role of exosomes in tumor progression and metastasis (review). Oncol Rep 35(3):1237–1244. https://doi.org/10.3892/or.2015.4507
Tang T-T, Lv L-L, Lan H-Y, Liu B-C (2019) Extracellular vesicles: opportunities and challenges for the treatment of renal diseases. Front Physiol 10:226–226. https://doi.org/10.3389/fphys.2019.00226
Théry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, Antoniou A, Arab T, Archer F, Atkin-Smith GK, Ayre DC, Bach J-M, Bachurski D, Baharvand H, Balaj L, Baldacchino S, Bauer NN, Baxter AA, Bebawy M, Beckham C, Bedina Zavec A, Benmoussa A, Berardi AC, Bergese P, Bielska E, Blenkiron C, Bobis-Wozowicz S, Boilard E, Boireau W, Bongiovanni A, Borràs FE, Bosch S, Boulanger CM, Breakefield X, Breglio AM, Brennan MÁ, Brigstock DR, Brisson A, Broekman MLD, Bromberg JF, Bryl-Górecka P, Buch S, Buck AH, Burger D, Busatto S, Buschmann D, Bussolati B, Buzás EI, Byrd JB, Camussi G, Carter DRF, Caruso S, Chamley LW, Chang Y-T, Chen C, Chen S, Cheng L, Chin AR, Clayton A, Clerici SP, Cocks A, Cocucci E, Coffey RJ, Cordeiro-da-Silva A, Couch Y, Coumans FAW, Coyle B, Crescitelli R, Criado MF, D’Souza-Schorey C, Das S, Datta Chaudhuri A, de Candia P, De Santana EF, De Wever O, del Portillo HA, Demaret T, Deville S, Devitt A, Dhondt B, Di Vizio D, Dieterich LC, Dolo V, Dominguez Rubio AP, Dominici M, Dourado MR, Driedonks TAP, Duarte FV, Duncan HM, Eichenberger RM, Ekström K, El Andaloussi S, Elie-Caille C, Erdbrügger U, Falcón-Pérez JM, Fatima F, Fish JE, Flores-Bellver M, Försönits A, Frelet-Barrand A, Fricke F, Fuhrmann G, Gabrielsson S, Gámez-Valero A, Gardiner C, Gärtner K, Gaudin R, Gho YS, Giebel B, Gilbert C, Gimona M, Giusti I, Goberdhan DCI, Görgens A, Gorski SM, Greening DW, Gross JC, Gualerzi A, Gupta GN, Gustafson D, Handberg A, Haraszti RA, Harrison P, Hegyesi H, Hendrix A, Hill AF, Hochberg FH, Hoffmann KF, Holder B, Holthofer H, Hosseinkhani B, Hu G, Huang Y, Huber V, Hunt S, Ibrahim AG-E, Ikezu T, Inal JM, Isin M, Ivanova A, Jackson HK, Jacobsen S, Jay SM, Jayachandran M, Jenster G, Jiang L, Johnson SM, Jones JC, Jong A, Jovanovic-Talisman T, Jung S, Kalluri R, S-i K, Kaur S, Kawamura Y, Keller ET, Khamari D, Khomyakova E, Khvorova A, Kierulf P, Kim KP, Kislinger T, Klingeborn M, Klinke DJ, Kornek M, Kosanović MM, Kovács ÁF, Krämer-Albers E-M, Krasemann S, Krause M, Kurochkin IV, Kusuma GD, Kuypers S, Laitinen S, Langevin SM, Languino LR, Lannigan J, Lässer C, Laurent LC, Lavieu G, Lázaro-Ibáñez E, Le Lay S, Lee M-S, Lee YXF, Lemos DS, Lenassi M, Leszczynska A, Li ITS, Liao K, Libregts SF, Ligeti E, Lim R, Lim SK, Linē A, Linnemannstöns K, Llorente A, Lombard CA, Lorenowicz MJ, Lörincz ÁM, Lötvall J, Lovett J, Lowry MC, Loyer X, Lu Q, Lukomska B, Lunavat TR, Maas SLN, Malhi H, Marcilla A, Mariani J, Mariscal J, Martens-Uzunova ES, Martin-Jaular L, Martinez MC, Martins VR, Mathieu M, Mathivanan S, Maugeri M, McGinnis LK, McVey MJ, Meckes DG, Meehan KL, Mertens I, Minciacchi VR, Möller A, Møller Jørgensen M, Morales-Kastresana A, Morhayim J, Mullier F, Muraca M, Musante L, Mussack V, Muth DC, Myburgh KH, Najrana T, Nawaz M, Nazarenko I, Nejsum P, Neri C, Neri T, Nieuwland R, Nimrichter L, Nolan JP, Nolte-‘t Hoen ENM, Noren Hooten N, O’Driscoll L, O’Grady T, O’Loghlen A, Ochiya T, Olivier M, Ortiz A, Ortiz LA, Osteikoetxea X, Østergaard O, Ostrowski M, Park J, Pegtel DM, Peinado H, Perut F, Pfaffl MW, Phinney DG, Pieters BCH, Pink RC, Pisetsky DS, Pogge von Strandmann E, Polakovicova I, Poon IKH, Powell BH, Prada I, Pulliam L, Quesenberry P, Radeghieri A, Raffai RL, Raimondo S, Rak J, Ramirez MI, Raposo G, Rayyan MS, Regev-Rudzki N, Ricklefs FL, Robbins PD, Roberts DD, Rodrigues SC, Rohde E, Rome S, Rouschop KMA, Rughetti A, Russell AE, Saá P, Sahoo S, Salas-Huenuleo E, Sánchez C, Saugstad JA, Saul MJ, Schiffelers RM, Schneider R, Schøyen TH, Scott A, Shahaj E, Sharma S, Shatnyeva O, Shekari F, Shelke GV, Shetty AK, Shiba K, Siljander PRM, Silva AM, Skowronek A, Snyder OL, Soares RP, Sódar BW, Soekmadji C, Sotillo J, Stahl PD, Stoorvogel W, Stott SL, Strasser EF, Swift S, Tahara H, Tewari M, Timms K, Tiwari S, Tixeira R, Tkach M, Toh WS, Tomasini R, Torrecilhas AC, Tosar JP, Toxavidis V, Urbanelli L, Vader P, van Balkom BWM, van der Grein SG, Van Deun J, van Herwijnen MJC, Van Keuren-Jensen K, van Niel G, van Royen ME, van Wijnen AJ, Vasconcelos MH, Vechetti IJ, Veit TD, Vella LJ, Velot É, Verweij FJ, Vestad B, Viñas JL, Visnovitz T, Vukman KV, Wahlgren J, Watson DC, Wauben MHM, Weaver A, Webber JP, Weber V, Wehman AM, Weiss DJ, Welsh JA, Wendt S, Wheelock AM, Wiener Z, Witte L, Wolfram J, Xagorari A, Xander P, Xu J, Yan X, Yáñez-Mó M, Yin H, Yuana Y, Zappulli V, Zarubova J, Žėkas V, Zhang J-y, Zhao Z, Zheng L, Zheutlin AR, Zickler AM, Zimmermann P, Zivkovic AM, Zocco D, Zuba-Surma EK (2018) Minimal information for studies of extracellular vesicles 2018 (MISEV 2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. Journal of Extracellular Vesicles 7(1):1535750. https://doi.org/10.1080/20013078.2018.1535750
Ucuzian AA, Gassman AA, East AT, Greisler HP (2010) Molecular mediators of angiogenesis. J Burn Care Res 31(1):158–175. https://doi.org/10.1097/BCR.0b013e3181c7ed82
Vader P, Breakefield XO, Wood MJ (2014) Extracellular vesicles: emerging targets for cancer therapy. Trends Mol Med 20(7):385–393. https://doi.org/10.1016/j.molmed.2014.03.002
Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654–659. https://doi.org/10.1038/ncb1596
Vella LJ (2014) The emerging role of exosomes in epithelial-mesenchymal-transition in cancer. Front Oncol 4:361–361. https://doi.org/10.3389/fonc.2014.00361
Wang L, Li Y, Guan X, Zhao J, Shen L, Liu J (2018) Exosomal double-stranded DNA as a biomarker for the diagnosis and preoperative assessment of pheochromocytoma and paraganglioma. Mol Cancer 17(1):128. https://doi.org/10.1186/s12943-018-0876-z
Wang H, Tan Z, Hu H, Liu H, Wu T, Zheng C, Wang X, Luo Z, Wang J, Liu S, Lu Z, Tu J (2019) microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1. BMC Cancer 19(1):738–738. https://doi.org/10.1186/s12885-019-5951-3
Wang J-P, Tang Y-Y, Fan C-M, Guo C, Zhou Y-H, Li Z, Li X-L, Li Y, Li G-Y, Xiong W, Zeng Z-Y, Xiong F (2017) The role of exosomal non-coding RNAs in cancer metastasis. Oncotarget 9(15):12487–12502. https://doi.org/10.18632/oncotarget.23552
Webber J, Steadman R, Mason MD, Tabi Z, Clayton A (2010a) Cancer Exosomes trigger fibroblast to Myofibroblast differentiation. Cancer Res 70(23):9621–9630. https://doi.org/10.1158/0008-5472.Can-10-1722
Webber J, Steadman R, Mason MD, Tabi Z, Clayton A (2010b) Cancer exosomes trigger fibroblast to myofibroblast differentiation. Cancer Res 70(23):9621–9630. https://doi.org/10.1158/0008-5472.Can-10-1722
Weidle UH, Birzele F, Kollmorgen G, Rüger R (2017) The multiple roles of Exosomes in metastasis. Cancer Genomics Proteomics 14(1):1–15. https://doi.org/10.21873/cgp.20015
Williams KC, Cepeda MA, Javed S, Searle K, Parkins KM, Makela AV, Hamilton AM, Soukhtehzari S, Kim Y, Tuck AB, Ronald JA, Foster PJ, Chambers AF, Leong HS (2019) Invadopodia are chemosensing protrusions that guide cancer cell extravasation to promote brain tropism in metastasis. Oncogene 38(19):3598–3615. https://doi.org/10.1038/s41388-018-0667-4
Wortzel I, Dror S, Kenific CM, Lyden D (2019) Exosome-mediated metastasis: communication from a distance. Dev Cell 49(3):347–360. https://doi.org/10.1016/j.devcel.2019.04.011
Xu J, Liao K, Zhou W (2018) Exosomes regulate the transformation of cancer cells in cancer stem cell homeostasis. Stem Cells Int 2018:4837370. https://doi.org/10.1155/2018/4837370
Xue XY, Liu YX, Wang C, Gu XJ, Xue ZQ, Zang XL, Ma XD, Deng H, Liu R, Pan L, Liu SH (2020) Identification of exosomal miRNAs as diagnostic biomarkers for cholangiocarcinoma and gallbladder carcinoma. Signal Transduct Target Ther 5(1):77. https://doi.org/10.1038/s41392-020-0162-6
Yamada N, Kuranaga Y, Kumazaki M, Shinohara H, Taniguchi K, Akao Y (2016) Colorectal cancer cell-derived extracellular vesicles induce phenotypic alteration of T cells into tumor-growth supporting cells with transforming growth factor-β1-mediated suppression. Oncotarget 7(19):27033–27043. https://doi.org/10.18632/oncotarget.7041
Yang R, Elsaadi S, Misund K, Abdollahi P, Vandsemb EN, Moen SH, Kusnierczyk A, Slupphaug G, Standal T, Waage A, Slørdahl TS, Rø TB, Rustad E, Sundan A, Hay C, Cooper Z, Schuller AG, Woessner R, Borodovsky A, Menu E, Børset M, Sponaas AM (2020) Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade. J Immunother Cancer 8(1):e000610. https://doi.org/10.1136/jitc-2020-000610
Yin Y, Cai X, Chen X, Liang H, Zhang Y, Li J, Wang Z, Chen X, Zhang W, Yokoyama S, Wang C, Li L, Li L, Hou D, Dong L, Xu T, Hiroi T, Yang F, Ji H, Zhang J, Zen K, Zhang CY (2014) Tumor-secreted miR-214 induces regulatory T cells: a major link between immune evasion and tumor growth. Cell Res 24(10):1164–1180. https://doi.org/10.1038/cr.2014.121
Yokoi A, Villar-Prados A, Oliphint PA, Zhang J, Song X, De Hoff P, Morey R, Liu J, Roszik J, Clise-Dwyer K, Burks JK, O’Halloran TJ, Laurent LC, Sood AK (2019) Mechanisms of nuclear content loading to exosomes. Sci Adv 5(11):eaax8849. https://doi.org/10.1126/sciadv.aax8849
Yuana Y, Sturk A, Nieuwland R (2013) Extracellular vesicles in physiological and pathological conditions. Blood Rev 27(1):31–39. https://doi.org/10.1016/j.blre.2012.12.002
Zhang H, Freitas D, Kim HS, Fabijanic K, Li Z, Chen H, Mark MT, Molina H, Martin AB, Bojmar L, Fang J, Rampersaud S, Hoshino A, Matei I, Kenific CM, Nakajima M, Mutvei AP, Sansone P, Buehring W, Wang H, Jimenez JP, Cohen-Gould L, Paknejad N, Brendel M, Manova-Todorova K, Magalhaes A, Ferreira JA, Osorio H, Silva AM, Massey A, Cubillos-Ruiz JR, Galletti G, Giannakakou P, Cuervo AM, Blenis J, Schwartz R, Brady MS, Peinado H, Bromberg J, Matsui H, Reis CA, Lyden D (2018) Identification of distinct nanoparticles and subsets of extracellular vesicles by asymmetric flow field-flow fractionation. Nat Cell Biol 20(3):332–343. https://doi.org/10.1038/s41556-018-0040-4
Zijlstra A, Di Vizio D (2018) Size matters in nanoscale communication. Nat Cell Biol 20(3):228–230. https://doi.org/10.1038/s41556-018-0049-8
Zitvogel L, Regnault A, Lozier A, Wolfers J, Flament C, Tenza D, Ricciardi-Castagnoli P, Raposo G, Amigorena S (1998) Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell derived exosomes. Nat Med 4(5):594–600. https://doi.org/10.1038/nm0598-594
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Shahi, S., Cianciarulo, C., Nedeva, C., Mathivanan, S. (2021). Extracellular Vesicles Regulate Cancer Metastasis. In: Mathivanan, S., Fonseka, P., Nedeva, C., Atukorala, I. (eds) New Frontiers: Extracellular Vesicles. Subcellular Biochemistry, vol 97. Springer, Cham. https://doi.org/10.1007/978-3-030-67171-6_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-67171-6_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-67170-9
Online ISBN: 978-3-030-67171-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)